Novartis Lp(a) drug fails to lower cardiovascular risk in closely watched ph. 3 trial Read more →

Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline Read more →

Menarini signs $771M deal to take Gan & Lee GLP-1 to European market Read more →